🔎 Trials Near Me

Utama › Kanser Prostat › New York › The Bronx

Kajian klinikal Kanser Prostat di The Bronx, NY

11 kajian untuk Kanser Prostat sedang mencari peserta di lokasi dalam dan sekitar The Bronx (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

Mengambil pesertaFasa 3
  • Montefiore Medical Center-Einstein Campus, The Bronx
  • Montefiore Medical Center - Moses Campus, The Bronx
Umur 18 ke atas · Lelaki · Dikemas kini 2 Okt 2026 · NCT07200830

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

Mengambil pesertaFasa 3
  • Montefiore Einstein Comprehensive Cancer Center, The Bronx
  • Montefiore Medical Center- Montefiore Medical Park, The Bronx
Umur 18 ke atas · Lelaki · Dikemas kini 24 Sep 2026 · NCT07028853

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

Mengambil pesertaFasa 2/3
  • Montefiore Medical Center, The Bronx
Umur 18 hingga 100 · Lelaki · Dikemas kini 22 Sep 2026 · NCT06780670

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

Mengambil pesertaFasa 3
  • Montefiore Medical Center, The Bronx
Umur 18 hingga 100 · Lelaki · Dikemas kini 22 Sep 2026 · NCT06855277

A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss

Mengambil pesertaFasa 2
  • James J. Peters VA Medical Center, Bronx, NY, The Bronx
Umur 18 ke atas · Lelaki · Dikemas kini 25 Ogo 2026 · NCT05593497

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Mengambil pesertaFasa 3
  • Montefiore Medical Center-Einstein Campus, The Bronx
  • Montefiore Medical Center-Weiler Hospital, The Bronx
  • Montefiore Medical Center - Moses Campus, The Bronx
Umur 18 ke atas · Lelaki · Dikemas kini 19 Ogo 2026 · NCT04423211

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

Mengambil pesertaFasa 1
  • Montefiore Medical Center, The Bronx
Umur 18 hingga 100 · Lelaki · Dikemas kini 13 Ogo 2026 · NCT05519449

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Mengambil pesertaFasa 3
  • Montefiore Medical Center-Einstein Campus, The Bronx
Umur 18 ke atas · Lelaki · Dikemas kini 14 Jul 2026 · NCT06592924

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

Mengambil pesertaFasa 2
  • James J. Peters VA Medical Center, The Bronx
Umur 18 ke atas · Lelaki · Dikemas kini 15 Jun 2026 · NCT05422911

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

Mengambil pesertaFasa 4
  • Montefiore Medical Center, The Bronx
Umur 18 hingga 100 · Lelaki · Dikemas kini 4 Jun 2026 · NCT05803941

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Mengambil pesertaFasa 3
  • Montefiore Medical Center-Einstein Campus, The Bronx
  • Montefiore Medical Center - Moses Campus, The Bronx
Umur 18 ke atas · Lelaki · Dikemas kini 11 Sep 2025 · NCT03678025

Kajian Kanser Prostat di bandar lain

Kajian lain di The Bronx

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.